If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,644.00    22.00 (0.84%)
Bid:
2,639.00
Ask:
2,641.00
Spread: 2.00 (0.076%)
Market Cap: £23.49b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Annual Financial Report

6 Jun 2025 11:30

RNS Number : 8322L
Experian plc
06 June 2025
 

Experian plc

 

 

Annual Report and Accounts for the year ended 31 March 2025, Notice of Annual General Meeting 2025 and Proxy Form

 

 

6 June 2025 - Experian plc, the global data and technology company (the "Company"), hereby notifies the market, in accordance with UK Listing Rule 6.4.1(R), that the above documents are being submitted to the National Storage Mechanism and they will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Copies of the Annual Report and Accounts and the Notice of Annual General Meeting are also available on the Company's website at www.experianplc.com.

 

The 2025 Annual General Meeting of the Company will be held at The Merrion Hotel, Upper Merrion Street, Dublin 2, D02 KF79, Ireland on Wednesday 16 July 2025 at 9.30am. A summary of the resolutions and the reasons they are being proposed is set out in the explanatory notes which accompany the Notice of Annual General Meeting.

 

 

Contact:

 

Experian

Claire Murphy Deputy Company Secretary +353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSBGGDLXDGDGUL
Date   Source Headline
24th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20259:30 amRNSDirector/PDMR Shareholding
13th Nov 20259:30 amRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSHalf-year Financial Report
31st Oct 202511:18 amRNSTotal Voting Rights
14th Oct 20251:00 pmRNSExperian – US mortgage market update
1st Oct 202510:24 amRNSAdditional Listing
30th Sep 202511:41 amRNSTotal Voting Rights
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20259:23 amRNSAdditional Listing
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 202510:07 amRNSBlock listing Interim Review
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 202510:00 amRNSDirector Declaration
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 202510:04 amRNSAdditional Listing
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20251:38 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20254:30 pmRNSDirector/PDMR Shareholding
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202512:50 pmRNSTotal Voting Rights
16th Jul 20251:58 pmRNSAppointment of Chair of the Remuneration Committee
16th Jul 20251:00 pmRNSResult of AGM
15th Jul 20257:00 amRNSTrading update, first quarter

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.